Fortovase approved: new saquinavir formulation.
James
J S
JS
D004304:Dosage Forms; D004334:Drug Administration Schedule; D016527:Drug Costs; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D019258:Saquinavir / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
D004304:Dosage Forms; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019258:Saquinavir